4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-23-037731
Options or other derivatives
- Director bought 19,311 shares at $2.86 ($55,268)
- Director acquired 0 shares (option exercise)
- Director acquired 18,888 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Pershing Edward · Director
Table II: Derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-10-03 | Purchase : show line 1 in the form Series D-1 Convertible Preferred Stock | +19,311 | $2.86 | $55,268 | 690,800 | D |
| 2023-10-14 | Exercise or conversion : show line 2 in the form 8% Unsecured Convertible Promissory Note | −0 | D | |||
| 2023-10-14 | Exercise or conversion : show line 3 in the form Series D-1 Convertible Preferred Stock | +18,888 | 709,688 | D |
Loading xslF345X05/ownership.xml…